Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001237334-25-000005
Filing Date
2025-10-27
Accepted
2025-10-27 16:30:41
Documents
1
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4049
  Complete submission text file 0001237334-25-000005.txt   5440
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
CAUSEY CHRISTOPHER (Reporting) CIK: 0001237334 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 251420246